Arctic Bioscience launches Romega® Skin Refine, a dietary supplement that builds on the company’s solid experience with advanced healthcare products, based on herring roe. Our new launch marks our entry into a large, global and growing market segment within “Beauty and Skincare”, with an estimated market size of 550-700 billion USD and growing with an estimated 7-8 % annually.
The product is already available on Romega.no, and during the third quarter of 2025 it will be launched in China, in collaboration with our partner Kotler Marketing Group China. The product will also be launched in Sweden this autumn and will mark the start of our subscription-based direct-to-consumer (B2C) expansion with a rollout in several European countries through 2026.
“We have a high level of expertise and solid experience in developing new products with herring roe oil, so this is a natural step forward for us”, says CEO Christer Valderhaug.
Romega® Skin Refine contains a unique combination of natural ingredients that support the skin’s beauty and vitality from within, with important nourishment for the skin.
“We are well aware of the unique properties of herring roe oil. Now we have combined this with other well-documented ingredients with benefits especially for the skin, and I believe that Romega® Skin Refine sets a completely new standard in natural skin care”, says Steffen Eidal, Commercial Director B2C at Arctic Bioscience.
“With over 30 years of experience in both product development and eCommerce, I know how important it is to offer products that are well-documented. Developing this product has taken both time and been demanding, but we know the importance this can have. We are proud to launch a product that provides both benefit and joy to customers, and at the same time elevates natural skin care to a whole new level. I dare say that there is no similar dietary supplement for the skin”, concludes Eidal.
More about the product: https://romega.no/produkt/romega-skin-refine/
For more information, kindly contact:
Christer L. Valderhaug
CEO
Mobil: +47 920 84 601
E-post: christer@arctic-bioscience.com
Steffen Eidal
Commercial Director B2C
Mobil: +47 906 30 450
E-post: steffen@arctic-bioscience.com
About Arctic Bioscience
Arctic Bioscience is a biotech company developing and commercializing pharmaceutical and nutraceutical products based on unique bioactive marine compounds.
The company is developing HRO350 – a novel oral drug candidate. HRO350 is being developed for treatment of patients with mild-to-moderate psoriasis. This is a large patient group in need of new effective medicines with beneficial safety profile.
Nutraceuticals from Arctic Bioscience are sold globally as bulk ingredients as well as finished goods under the ROMEGA® brand.
Arctic Bioscience is led by a highly skilled team of talents with diverse and highly relevant background.